These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 28054442)

  • 1. Markers and function of human NK cells in normal and pathological conditions.
    Del Zotto G; Marcenaro E; Vacca P; Sivori S; Pende D; Della Chiesa M; Moretta F; Ingegnere T; Mingari MC; Moretta A; Moretta L
    Cytometry B Clin Cytom; 2017 Mar; 92(2):100-114. PubMed ID: 28054442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human natural killer cells: origin, receptors, function, and clinical applications.
    Moretta L; Montaldo E; Vacca P; Del Zotto G; Moretta F; Merli P; Locatelli F; Mingari MC
    Int Arch Allergy Immunol; 2014; 164(4):253-64. PubMed ID: 25323661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human NK cells: From surface receptors to clinical applications.
    Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
    Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation.
    Pende D; Falco M; Vitale M; Cantoni C; Vitale C; Munari E; Bertaina A; Moretta F; Del Zotto G; Pietra G; Mingari MC; Locatelli F; Moretta L
    Front Immunol; 2019; 10():1179. PubMed ID: 31231370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.
    Locatelli F; Pende D; Mingari MC; Bertaina A; Falco M; Moretta A; Moretta L
    Front Immunol; 2013; 4():15. PubMed ID: 23378843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation.
    Marcenaro E; Carlomagno S; Pesce S; Della Chiesa M; Moretta A; Sivori S
    J Leukoc Biol; 2011 Oct; 90(4):661-7. PubMed ID: 21791599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.
    Moretta L; Locatelli F; Pende D; Marcenaro E; Mingari MC; Moretta A
    Blood; 2011 Jan; 117(3):764-71. PubMed ID: 20889923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
    Moretta A; Locatelli F; Moretta L
    Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.
    Sivori S; Vacca P; Del Zotto G; Munari E; Mingari MC; Moretta L
    Cell Mol Immunol; 2019 May; 16(5):430-441. PubMed ID: 30778167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.
    Pende D; Marcenaro S; Falco M; Martini S; Bernardo ME; Montagna D; Romeo E; Cognet C; Martinetti M; Maccario R; Mingari MC; Vivier E; Moretta L; Locatelli F; Moretta A
    Blood; 2009 Mar; 113(13):3119-29. PubMed ID: 18945967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias.
    Moretta A; Pende D; Locatelli F; Moretta L
    Clin Exp Immunol; 2009 Sep; 157(3):325-31. PubMed ID: 19664139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging innate NK cell functions with adaptive immunity.
    Marcenaro E; Carlomagno S; Pesce S; Moretta A; Sivori S
    Adv Exp Med Biol; 2011; 780():45-55. PubMed ID: 21842364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation.
    Rathmann S; Glatzel S; Schönberg K; Uhrberg M; Follo M; Schulz-Huotari C; Kaymer M; Veelken H; Finke J; Fisch P
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):469-81. PubMed ID: 20044012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human NK receptors: from the molecules to the therapy of high risk leukemias.
    Moretta L; Locatelli F; Pende D; Sivori S; Falco M; Bottino C; Mingari MC; Moretta A
    FEBS Lett; 2011 Jun; 585(11):1563-7. PubMed ID: 21554879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
    Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
    Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Risk Leukemia: Past, Present, and Future Role of NK Cells.
    Mavers M; Bertaina A
    J Immunol Res; 2018; 2018():1586905. PubMed ID: 29850617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells in the treatment of high-risk acute leukaemia.
    Locatelli F; Moretta F; Brescia L; Merli P
    Semin Immunol; 2014 Apr; 26(2):173-9. PubMed ID: 24613727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Perruccio K; Aversa F; Martelli MF; Velardi A
    Semin Cancer Biol; 2006 Oct; 16(5):404-11. PubMed ID: 16916611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
    Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
    Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.